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Summary In a cross-sectional study, we investigated the relationship between age, physical health, social and economic resources,
functional status, activities of daily living (ADL) and disease-related variables of 227 patients with cancer. Using multidimensional outcome
measures we examined age differences in three age groups (< 45, 46-65, >65 years) and identified predictors of performing ADL. The results
indicated that older patients have outcomes similar to those of younger patients. There were no significant differences in quality of life,
performance status and physical health among the three age groups. The only areas where age-related differences were found were co-
morbidity and cancer-related impairments. Patients aged 45-65 years and patients 65 years and older reported a higher level ofco-morbidity
and more cancer-related impairments than those aged 45 and younger. Although older patients had higher co-morbidity, they showed similar
Karnofsky Performance Status (KPS) scores to those of their younger counterparts. The regression analysis revealed social resources, self-
reported health, performance status and complexity of care as significant predictors of patients' ADL, but not age, co-morbidity or severity of
treatment. The findings support the conclusion that differences in performing ADL between younger and older patients with cancer are
minimal and tend to be due to co-morbidity. Thus, treatment should be decided by a patient's physical health rather than by age.
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The ageing of the general population has increased the incidence
of chronic disease and disabilities. In the United States, cancer is
the leading cause of death in women aged 55-74 and the second
leading cause of death in men aged 55 and older (Wingo et al,
1995). Consequently, age has become an important focus of
research. A number of studies have revealed age effects in the
selection of screening evaluations and treatment procedures in
various cancer samples (Guadagnoli et al, 1990; Liberati et al,
1991; Bennet et al, 1991). For the elderly, co-morbidity, shortened
life expectancy and limitations in physical functioning are impor-
tant considerations in medical decision making (Balducci, 1994).
Treatment bias related to age has been reported by several authors
(Greenfield et al, 1987; Grover et al, 1989; Silliman et al, 1989).
Forexample, Guadagnoli et al (1990), found that olderlung cancer
patients diagnosed with local disease were less likely to receive
appropriate treatment than younger patients. Similarly, there is
evidence that the age of women with breast cancer influences
medical treatment decisions (Greenfield et al, 1987; Liberati et al,
1990; Lazovich et al, 1991).
Recently, the prognostic value of age in determining patients'
physical and psychosocial outcomes has been investigated more
extensively (Reuben et al, 1988; Wolf et al, 1991; Given et al,
1994). These studies revealed that age is a poor predictor for
survival (Vinokur et al, 1990; Ganz et al, 1992), as well as for
psychosocial well-being in cancer patients (Goodwin et al, 1991;
Moor et al, 1994). In contrast, Vinokur et al (1990) identified age
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as an important predictor ofphysical and psychological well-being
in women with breast cancer (Lauria, 1991). Improved emotional
responses and fewer rehabilitation problems were found in older
rather than in younger cancer patients (Vinokur et al, 1990; Ganz
et al, 1992; Moor et al, 1994).
Studies have confirmed that advancing age is associated with
functional disabilities, dependence in activities of daily living
(ADL), and greater co-morbidity (Goodwin et al, 1991; Lauria,
1991; Balducci, 1994). Other investigators reported no significant
relationship between age and functional status (Vinokur et al,
1990; Ganz et al, 1992; Given et al, 1994). Current trends in health
care aim to reduce hospital beds in acute care units. Thus, patients
are being discharged with high levels of dependency (Fillenbaum
et al, 1981). As physical health status declines with advanced age,
older patients with cancer may have more difficulties in
performing self-care activities in daily living after discharge from
hospital than do younger patients.
Thus, the present study examines the effect of age on the
relations among physical health, social and economic resources,
functional status, ADL and disease-related variables in a cancer
sample referred to home care. Furthermore, the predictive value of
age for patients' performance in ADL after cancer treatment was
investigated.
METHOD
Two hundred and twenty seven patients were recruited from ten
hospitals within different geographic areas ofLos Angeles during
a 42-month time period. All discharges referred to home care were
considered for the sample. Subjects were 162 women and 65 men.
Patients were eligible for the study ifthey were (1) diagnosed with
cancer stage I to IV; (2) discharged from the hospital with a physi-
cian's order for home care; (3) spoke English; and (4) consented to
251252 ER Greimel et al
Table 1 Demographic characteristics, frequencies and percentages
Variable n %
Sex
Female 162 72
Male 65 28
Age (mean 59 years)
21-25 3 1
26-35 9 4
36-45 25 11
46-55 49 22
56-65 57 25
66-75 63 28
76-85 19 8
86-88 2 1
Marital Status
Married 117 52
Divorced/Separated 54 24
Widowed 38 17
Single 16 7
Ethnicity
White 178 79
Hispanic 28 13
Black 10 4
Asian 9 4
Education
High school or less 107 49
College graduate 92 41
Postgraduate 23 10
Employment status
Working 79 37
Retired 124 57
Unemployed 13 6
Annual income (US $)
<9 999 61 30
10 000-29 999 83 40
30000-44999 21 10
>45000 41 20
participate. Patients were approached during the predischarge and
discharge period by trained research assistants. All patients had
completed their current medical treatment. Informed consent
was obtained from all participants. Data were collected before
discharge from hospital with a set ofquestionnaires.
The questionnaire battery included biographical and disease-
related data, quality of life assessments and measurements of
functioning. The OARS Multidimensional Functional Assessment
Questionnaire (OMFAQ) was used to assess five areas: physical
health, mental health, economic resources, social resources and
ADL (Fillenbaum et al, 1988). This questionnaire provides patient
self-report data and interviewer ratings for each area. The
Karnofsky performance status (KPS) scale was used to assess the
physical status ofcancer patients with scores from 0 (dead) to 100
(normal functioning) (Karnofsky et al, 1949). The Quality of Life
Cancer Scale (QOL-CA) was designed to measure patients'
health-related quality of life based on a multidimensional concept
(Padilla et al, 1983). This instrument consists of30 questions rated
on a visual analogue scale from 0 to 100. Patients indicated their
quality oflife by placing a mark on this continuum that represents
their present state of well-being. The Diagnosis, Treatment and
Management Variables Tool (DTMVT), developed by the investi-
gators, elicited information about hospital discharge diagnosis,
Table 2 Clinical characteristics, frequencies and percentages
Variable n %
Site of cancer
Breast 77 34
Colorectal 44 19
Genitourinary 40 18
Head and neck 20 9
Gynaecological 19 8
Lung 13 6
Other diagnoses 14 6
Cell type
Carcinoma 126 57
Adenocarcinoma 74 33
Sarcoma 5 2
Other 17 8
Cancer stage (TNM)
1 43 19
11 49 22
III 56 28
IV 30 31
Current treatment
Surgery 39 17
First-line chemotherapy 63 28
Second-line chemotherapy 57 26
First-line radiation therapy 37 17
Second-line radiation therapy 28 12
severity of medical treatments and complexity of home care.
Diagnosis was defined as site of cancer, stage and cell type.
Severity of medical treatment was defined as the severity of each
medical procedure applied to the patient: surgery, radiation,
chemotherapy or othertreatment. Each type oftreatment was inde-
pendently classified case by case by the research team on a four-
point scale ranging from 0 'not at all' to 3 'very severe' and added
to provide a summary score (range 0-12). Complexity of care
problems and procedures was defined by the number of general,
eliminative, skin, oral, chest, digestive, cardiovascular and neuro-
muscular problems at time of discharge (range 0-14). The co-
morbidity score was based on a single item asking patients about
their current and past health problems. The number ofillnesses, as
well as the extent of their interference with daily life, were added.
The co-morbidity score ranged from 0 to 14, with higher numbers
indicating a higher level ofco-morbid condition.
Descriptive statistics were used to analyse demographic and
clinical characteristics of the sample. Age differences were
ascertained with analyses ofvariance (ANOVA) and chi-square. A
backward stepwise multiple regression analysis was applied to
evaluate the extent to which patients' age was related to physical
performance of ADL. This procedure indicates the independent
influence of age. The potential confounding effects of cancer
stage, gender and education were controlled for in the statistical
analyses. Data analyses were performed using the SAS software
(SAS, 1989).
RESULTS
During the study 268 patients were recruited; of these, 16 refused
consent and 25 felt too ill to complete the questionnaires. A
sample of 227 subjects participated in the study. In Table 1 demo-
graphic characteristics ofthe sample are presented.
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Table 3 Age differences in comorbidity and disease-related variables
Age (years)
< 45 45-65 >65 F
Co-morbidity (total score) 3.0 ± 0.9 4.3 ± 2.2 5.2 ± 2.1 13.7a
Past health problems 1.4 ± 1.0 2.7 ± 1.9 3.8 ± 2.0 21.4a
Current health problems 1.7± 0.8 2.7 ± 1.6 3.8 ± 1.6 20.0a
Interference with daily life 3.7 ± 2.7 5.6 ± 4.0 7.1 ± 4.0 10.4a
Cancer-related impairments 6.2 ± 2.4 6.3 ± 2.2 7.2 ± 2.0 4.2a
Medications taken 5.2 ± 2.7 6.0 ± 3.3 6.2 ± 3.0 1.3
Severity of treatment 5.6 ± 2.0 5.1 ± 1.9 4.7 ± 1.8 3.0
Complexity of care 5.8 ± 2.4 5.7 ± 2.0 6.0 ± 2.0 0.8
KPS 55.2 ± 12.5 60.3± 12.1 58.9± 13.9 0.2
ap< 0.01; ANOVA with two degrees of freedom; values are means ± s.d.
Table 4 Correlation matrix of dependent variables
Age Social resources Physical health KPS Comorbidity Complexity of care Treatment
Age
Social resources -0.04
Physical health 0.03 -0.21a
KPS 0.00 -0.07 0.36a
Co-morbidity 0.36a -0.05 -0.27a -0.28a
Complexity of care 0.04 0.04 0.18b J0.40a 0.40a
Severity of treatment -0.17b 0.13 -0.07 -0.03 0.18 -0.05
ap< 0.001. bp< 0.05.
Table 5 Regression model with ADL as the dependent variable
Multivariate Standard Univariate Standard
Variable (range) coefficient error t-values coefficient error t-values
Age (21-88 years) -0.005 0.003 -1.366 -0.006 0.005 -1.131
Social resources (0-4)a -0.043 0.018 -2.390c -0.003 0.031 -0.089
Physical health (3-10)b -0.113 0.025 -4.460d -0.263 0.036 -7.324d
KPS (10-90)a 0.059 0.004 15.545d 0.069 0.003 20.289d
Co-morbidity (2-14)b -0.028 0.023 -1.192 -0.180 0.032 -5.661d
Complexity of care (2-13)b -0.069 0.025 -2.767c -0.246 0.033 _7.485d
Severity of treatment (0-9)b -0.023 0.022 -1.051 -0.019 0.039 -0.480
R-square = 0.71; aHigher scores indicate better social resources and better performance status. bHigher scores indicate poorer outcomes (e.g. more health
problems). cp< 0.05; dp< 0.01.
Study participants tended to be women, white and retired or unem-
ployed with annual incomes below US $30 000. Subjects were
equally likely to be married or unmarried and to have a
college/high-school degree or less. Most patients were between 45
and 65 years of age or over 65 with a mean of 59 years. Age and
gender distributions conform with the incidence pattern of cancer
in adults (Wingo et al, 1995).
Table 2 shows the clinical characteristics, site of cancer, cell
type and current treatment. The patients suffered from various
kinds of cancer, of which breast cancer (34%), colorectal cancer
(19%), and genitourinary cancer (18%) were the most common.
More than one-third of the subjects were diagnosed with breast
cancer, which explains the high proportion of women in the
sample. Among the cell types, carcinoma and adenocarcinoma
were the most frequent. The cancer stages according to the TNM
classification had the following distribution: stage I, 19%; stage II,
22%; stage III, 28%; and stage IV, 31%. At time ofdischarge 17%
had surgery, 54% first- or second-line chemotherapy and 29%
radiation therapy.
The KPS scores range from 30 to 90 (mean = 59; s.d. = 13).
Most of the 227 subjects were able to care for themselves with
varying amounts of assistance from others. None of the patients
was completely unable to perform basic ADL, required permanent
institutional or hospital care (KPS score < 20) or vice versa, i.e.
had no complaints or were able to carry on normal activities
without assistance (KPS score > 80).
Using ANOVA we analysed age effects on physical and
psychosocial outcomes. We divided the sample into three groups:
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patients less than 45 years of age (24 women, nine men), patients
between 45 and 65 years ofage (85 women, 23 men), andpatients
older than 65 years of age (52 women, 31 men). A group compar-
ison revealed no statistically significant age differences on the
KPS scale (F = 2.02, P < 0.05).
The quality of life data were analysed in the same fashion. The
overall QOL-CA scores were normally distributed within a range
from 22 to 78 (mean = 55; s.d. = 11). The mean scores for the
subscales were: psychological-existential well-being mean = 68,
s.d. = 17, range 21-98; physical-functionalwell-being mean =68,
s.d. = 16, range 23-99; symptom distress mean = 68, s.d. = 16,
range 23-99; and attitude of worry mean = 63, s.d. = 23, range
4-99. The ANOVA results showed no age differences in any ofthe
investigated QOL-CA scores among the three age groups neither
in the subscales psychological-existential well-being (F = 0.03,
P > 0.05), physical-functional well-being (F = 0.28, P > 0.05),
symptom distress (F = 0.04, P > 0.05) and attitude of worry
(F = 0.03, P > 0.05) or in the total QOL-CA score (F = 0.61,
P > 0.05) (not shown in the table).
Patient-specific variables concerning personal resources and
health assessments were obtained from self-reports and inter-
viewer ratings by the OMFAQ. Overall, the patient self-reports
were consistent with the interviewer-rated scores. However, in the
area of economic resources the interviewer rated the economic
security of older individuals slightly better than did the patients.
Using the score based on patients' self-reports the differences
among the investigated groups were not significant (F = 2.96,
P > 0.05), whereas the interviewer-rated score indicated statisti-
cally significant age differences. Older patients showed a higher
level of economic security than younger patients (F = 3.14,
P < 0.05). In the area of social resources, patients in the younger
age groups (<45; 45-65 years ofage) had significantly more live-
in resources than patients 65 years of age and above (F = 13.66,
P < 0.05). No significant age differences were found for mental
health, physical health, self and interviewer-rated ADL scores.
Strong age effects were evident in resultsconcerning co-morbid
illnesses and cancer-related impairments. Table 3 shows the
differences among the three age groups concerning co-morbidity,
severity of treatment and complexity of care.
The results showed thatpatients older than 65 years ofage have
a significantly higher level ofco-morbidity than patients 65 years
of age and younger (F = 13.7, P < 0.05). Older patients reported
significantly more healthproblems in the past as well as currently,
which interfered with theirdaily life to a greater extent than it did
in younger patients. Although older cancer patients had a higher
co-morbidity, their KPS scores were similar to that of younger
patients. Olderpatients were morelikely to have otherhealthprob-
lems, independent oftheir cancerdiagnosis, thatimpacted on their
current health. No statistically significant differences were found
in the complexity of care patients received and the severity of
treatment, although younger patients were treated slightly more
aggressively. Regarding cancer-specific impairments, there was a
significant difference between the younger and the older age
group. Older patients reported significantly more impairments
related to disease and treatment than their younger counterparts
(F = 4.22, P < 0.05).
A multiple regression analysis was conducted to determine
which variables contributed most significantly to the patients'
performance in ADL. In the model, the interviewer-rated ADL
score was used as the dependent variable. As explanatory factors
variables that are relevant for assessing patient outcomes and
for clinical decision making were used. The following factors were
included in the model: age, social resources, perceived physical
health, KPS, level ofco-morbidity, complexity ofcare and severity
oftreatment (Table 4).
The correlation matrix ofthe independent variables shows scores
ranging from 0.04 to -0.40, indicating that the variables are largely
independent. Table 5 presents the results ofthe multivariate and the
univariate regression analyses. The coefficients show the relative
importance ofeach possible explanatory factoron the outcome vari-
able. The model explains 71% ofthe variance (P < 0.01). Perceived
physical health (t = -4.460, P < 0.01), complexity of care (t =
-2.767, P = < 0.01), and the KPS (t = 15.545, P < 0.01) accounted
for the most variance in the judgment about patients' ability to
performADL. Social resources also made a significantcontribution
to the model (t = -2.390, P = < 0.05), whereas age was not signifi-
cant. Severity of treatment and co-morbidity were the poorest
predictors ofphysical performance ofADL. The effect ofage in the
multivariate analyses was similar in the univariate analyses.
DISCUSSION
This paper reported results concerning age effects in a sample of
227 patients with cancer. Overall, these results suggest that
increasing age does not appear to significantly diminish physical
outcomes of adult cancer patients. However, the findings revealed
age differences for specific impairments related to disease and
treatment. Older patients reported significantly more cancer-
related limitations than younger patients. This finding is not
surprising and parallels the results of a prostate cancer study in
which older men were more likely to have clinical symptoms than
younger men (Bennet et al, 1991).
The results demonstrated a positive relationship between age
and co-morbidity. Compared with younger subjects, patients older
than 65 years were more likely to have a higher number of health
problems. The relationship between ageing, loss offunctional abil-
ities and increased incidence of chronic medical condition has
been documented in previous longitudinal studies (Harris et al,
1989; Guralnik et al, 1989; Boult et al, 1994). In this sample there
was a considerable portion of patients advanced in years with a
higher number ofco-morbid illnesses.
An increased level of co-morbidity is not necessarily related to
poor perceived health. This is supported by Lindgren et al (1994),
who found that the elderly rated their health as good, despite the
fact that they had numerous functional limitations. According to
our results and those of Mor et al (1992), co-morbidity appears to
be reflected in specific cancer-related impairments but not in
general physical health. As the regression analyses results indi-
cated, co-morbidity was a poor predictor ofperformance ofADL.
In this study, age was not related to different areas of QOL.
Previous studies have suggested that age is related positively to
emotional functioning (Vinokur et al, 1990; Ganz et al, 1992;
Moor et al, 1994). In this sample, older individuals did not have
better scores on the subscale psychological well-being, as
measured by the QOL-CA scale, than younger patients.
Examining the predictive value of age and confounding vari-
ables such as gender, education and cancer stage we found that
social resources, perceived physical health, KPS and complexity
ofcare were significantly related to physical performance in ADL.
Patients' evaluation of their health and the KPS rated by experts
were equally important in predicting this outcome. Our findings,
like those of several other investigators, suggest that age and
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co-morbidity are relatively poor predictors of patient outcomes
(Ganz et al, 1990; Given et al, 1994). Among the explanatory vari-
ables used in the regression model, severity of treatment had the
least predictive value. Ganz et al (1992) showed that the type of
treatment in patients undergoing breast conservation therapy vs
patients having mastectomy did not impact differently on their
quality oflife.
Our findings support the conclusion that differences in the
health perception between younger and older patients with cancer
are minimal and tend to be due to co-morbidity. Age and co-
morbidity are poor predictors ofphysical performance as measured
by ADL. The complex relationships between sociodemographic
characteristics and factors related to disease and treatment need to
be considered carefully in clinical decision making.
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